Dr. Mark F. Hollingsworth, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2287 |
Dr. Derrick S. Fung, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 Fax: 254-724-7791 |
Dr. Austin Wei Chang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1905 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-773-7785 Fax: 254-778-7197 |
Kendall Bicknell, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1901 Veterans Memorial Dr, Temple, TX 76504 Phone: 254-743-0728 |
Dr. J Paul Dieckert, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Corey Breland Parish, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Todd Bradley Gorden, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1618 Canyon Creek Dr, Suite 120, Temple, TX 76502 Phone: 254-791-2020 Fax: 254-791-2025 |
Dr. Robert H. Rosa Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Robert D. Davis, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Mark Morgan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1815 S 31st St, Temple, TX 76504 Phone: 254-724-2111 |
Mark Stephen Foster, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1901 S 1st St, Temple, TX 76504 Phone: 254-743-0728 Fax: 254-743-0128 |
Dr. Calvin G. Eshbaugh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
David Liang, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1901 Veterans Memorial Dr # 112, Temple, TX 76504 Phone: 254-743-0728 Fax: 254-743-0128 |
Dr. Louis W. Adams, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Matthew Recko, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-3937 |
Dr. Susan Jane Dittmar, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1901 S 1st St, Central Texas Veterans Health Care System, Temple, TX 76504 Phone: 254-743-2890 Fax: 254-743-9976 |
Dr. Kyle H. Smith, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Samuel F. Fulcher, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |
Dr. Brent Rocke, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1815 S 31st St, Temple, TX 76504 Phone: 254-724-2111 |
Joseph Newman, Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-1508 |
News Archive
Penn Medicine researchers, in a continuation of their groundbreaking work to better understand how anesthesia works in the body, have found the first new class of novel anesthetics since the 1970s. Their findings, published in February issue of Anesthesiology, detail the processes through which the group uncovered these compounds.
Micrus Endovascular Corporation today announced receipt of Shonin approval from the Ministry of Health, Labour and Welfare to market in Japan its novel bare platinum and Cerecyte® DeltaPaq™ filling and DeltaPlush™ finishing microcoils for the treatment of cerebral aneurysms and treatments in the peripheral vasculature.
Homeless young people are victims of crime at rates that society would consider unacceptable for any other group, according to a new report by researchers at York University and the University of Guelph.
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
Years of diabetes research carried out on mice whose DNA had been altered with a human growth hormone gene is now ripe for reinterpretation after a new study by researchers at KU Leuven confirms that the gene had an unintended effect on the mice's insulin production, a key variable in diabetes research.
› Verified 7 days ago